Visual Hallucinations and α-Synuclein Oligomers in Dementia with Lewy Bodies (DLB)
Objective: To determine whether visual hallucinations (VH) in dementia with Lewy bodies (DLB) are associated with α-synuclein oligomers. Background: It is not known whether VH…Abnormal Top-down Perceptual Modulation Drives Visual Hallucinations in Parkinson’s Disease
Objective: Assess performance on computerized illusions across PD patients with (PD_Hal) and without (PD_NonHal) history of visual hallucinations and explore underlying cortical substrates. Background: In…Misinterpretation of Hypnagogic/hypnopompic Experiences as Hallucinations in Parkinson’s Disease
Objective: To investigate whether hypnagogic/hypnopompic experiences are clinically misinterpreted as hallucinations in Parkinson’s disease. Background: In Lewy body disorders, the progression of the disease can…Safety of Pimavanserin for Parkinson’s Disease Psychosis: Exploratory Analysis of Sedation and Sleep Data From Clinical Studies
Objective: To summarize the sleep and sedation-related safety and tolerability of pimavanserin for the treatment of Parkinson’s disease psychosis (PDP). Background: Pimavanserin, a 5-HT2A receptor…Prevalence of non-motor symptoms and their impact in quality of life in PD: a Mexican Registry, 2011-2019 (the ReMePark-2 study).
Objective: To determine the prevalence of non-motor symptoms (NMS) and their impact on quality of life (QoL) in Mexican individuals with Parkinson's disease (PD), aiming…Unmet Motor and Nonmotor Needs of People with Parkinson’s in the Final Year of Life
Objective: To assess main issues People with Parkinson’s (PD, PwP) wished to discuss at clinical consultations with movement disorders specialists during the final year of…Novel digital marker detects minor hallucinations online at home of patients with Parkinson’s disease
Objective: The aim is to develop a novel implicit and quantitative marker for minor hallucinations (MH) in Parkinson’s disease (PD) for a better tracking of…Functional connectivity fingerprints in Parkinson’s disease patients with hallucinations
Objective: Investigate functional connectivity (FC) fingerprints of Minor Hallucinations (MH) in Parkinson’s Disease (PD). Background: MHs occur at the early stages of Parkinson’s disease in…Early cognitive decline in Parkinson’s disease is anticipated by enhanced frontal theta oscillations and minor hallucinations
Objective: Identify alterations associated with minor hallucinations (MH) and their role in cognitive decline in patients with Parkinson’s disease (PD) by merging electroencephalography (EEG) with…Diplopia (Double vision) in Parkinson’s disease patients: prevalence and nonmotor effect
Objective: To assess the prevalence of diplopia in Parkinson’s disease (PD) patients and the correlation of diplopia with visual hallucinations, cognitive dysfunction and motor performance.…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 11
- Next Page »